{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:08:40Z","timestamp":1758935320138},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T00:00:00Z","timestamp":1451347200000},"content-version":"vor","delay-in-days":4655,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1046\/j.1523-1755.2003.00879.x","type":"journal-article","created":{"date-parts":[[2004,12,27]],"date-time":"2004-12-27T18:25:49Z","timestamp":1104171949000},"page":"1548-1555","source":"Crossref","is-referenced-by-count":20,"title":["Depolymerized holothurian glycosaminoglycan (DHG), a novel alternative anticoagulant for hemodialysis, is safe and effective in a dog renal failure model"],"prefix":"10.1016","volume":"63","author":[{"given":"Kazuhisa","family":"Minamiguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko T.","family":"Kitazato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuo","family":"Ohwada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Kitazato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000182111","article-title":"Hemorrhage during high-risk hemodialysis using controlled heparinization","volume":"28","author":"Swartz","year":"1981","journal-title":"Nephron"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0015","first-page":"590","article-title":"Heparin-free hemodialysis with cuprophan hollow fiber dialyzer by a frequent-saline-flush, high-blood-flow technique","volume":"31","author":"Agresti","year":"1985","journal-title":"Am Soc Artif Intern Organs"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0020","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0140-6736(78)92328-0","article-title":"Dialysis death and increased free fatty acids","volume":"2","author":"Bergrem","year":"1978","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0025","first-page":"546","article-title":"Utility of FUT-175, an enzyme inhibitor, in hemodialysis\u2014Its anticoagulative and anticomplement actions","volume":"15","author":"Kinugasa","year":"1982","journal-title":"J Jpn Soc Dial Ther"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0030","first-page":"334","article-title":"The usefulness of the multienzyme inhibitor nafamostat mesilate in high-bleeding-risk hemodialysis","volume":"22","author":"Akizawa","year":"1985","journal-title":"Proc Eur Dial Transplant Assoc"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0035","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000187357","article-title":"Nafamostat mesilate: A regional anticoagulant for hemodialysis in patients at high risk for bleeding","volume":"64","author":"Akizawa","year":"1993","journal-title":"Nephron"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0040","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1159\/000045840","article-title":"Low molecular weight heparin in hemodialysis patients with a bleeding tendency","volume":"86","author":"Leu","year":"2000","journal-title":"Nephron"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0045","first-page":"541","article-title":"Effects of low molecular weight heparin as an anticoagulant for hemodialysis patients with bleeding risk. Multiinstitutional control study with low dose or regional heparinization","volume":"19","author":"Koshikawa","year":"1991","journal-title":"Clin Eval"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0050","first-page":"176","article-title":"Comparative clinical trial of regional anticoagulation for hemodialysis","volume":"34","author":"Akizawa","year":"1988","journal-title":"Am Soc Artif Intern Organs Trans"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0055","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJM199503093321018","article-title":"Hyperkalemia due to nafamostat mesilate","volume":"332","author":"Kitagawa","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0060","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000045822","article-title":"Anaphylactoid reaction induced by a protease inhibitor, nafamostat mesilate, following nine administrations in a hemodialysis patient","volume":"86","author":"Higuchi","year":"2000","journal-title":"Nephron"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0065","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000045892","article-title":"Anaphylactoid reaction induced by low-molecular-weight heparin in a hemodialysis patient","volume":"87","author":"Ueda","year":"2001","journal-title":"Nephron"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0070","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1592\/phco.20.9.771.35210","article-title":"Enoxaparin and bleeding complications: A review in patients with and without renal insufficiency","volume":"20","author":"Gerlach","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0075","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1016\/S0040-4039(00)61245-5","article-title":"Structure of DHG, a depolymerized glycosaminoglycan from sea cucumber, Stichopus japonicus","volume":"33","author":"Yoshida","year":"1992","journal-title":"Tetrahedron Lett"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0080","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1182\/blood.V85.6.1527.bloodjournal8561527","volume":"85","author":"Nagase","year":"1995","journal-title":"Blood"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/oxfordjournals.jbchem.a021217","article-title":"Effect of depolymerized holothurian glycosaminoglycan (DHG) on the activation of factor VIII and factor V by thrombin","volume":"119","author":"Nagase","year":"1996","journal-title":"J Biochem"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0090","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1055\/s-0038-1655975","article-title":"Antithrombin III-independent effect of a new depolymerized holothurian glycosaminoglycan (DHG) on acute thromboembolism in mice","volume":"77","author":"Nagase","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0049-3848(96)00166-1","article-title":"DHG, a new depolymerized holothurian glycosaminoglycan, exerts an antithrombotic effect with less bleeding than unfractionated or low-molecular-weight heparin, in rats","volume":"84","author":"Kitazato","year":"1996","journal-title":"Thromb Res"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0100","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1055\/s-0038-1656128","article-title":"The anticoagulant and hemorrhagic effects of DHG, a new depolymerized holothurian glycosaminoglycan, on experimental hemodialysis in dogs","volume":"77","author":"Minamiguchi","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0049-3848(96)00134-X","article-title":"Interaction of a new depolymerized holothurian glycosaminoglycan with proteins in human plasma","volume":"83","author":"Minamiguchi","year":"1996","journal-title":"Thromb Res"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0110","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/oxfordjournals.jbchem.a135187","article-title":"A method for systematic purification from bovine plasma of six vitamin-K-dependent coagulation factors: Prothrombin, factor X, factor IX, protein S, protein C, and protein Z","volume":"97","author":"Hashimoto","year":"1985","journal-title":"J Biochem"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0115","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0021-9258(19)43070-6","article-title":"The conversion of prothrombin to thrombin","volume":"249","author":"Owen","year":"1974","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0120","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1172\/JCI108710","article-title":"Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes","volume":"59","author":"Craddock","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0125","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.1016\/S0021-9258(18)32276-2","article-title":"Activation of heparin cofactor II by dermatan sulfate","volume":"258","author":"Tollefsen","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0130","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0140-6736(92)91650-W","article-title":"Dermatan sulphate in hemodialysis","volume":"339","author":"Lane","year":"1992","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0135","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0049-3848(89)90198-9","article-title":"Profibrinolytic activities of chemically modified heparins with very low anticoagulant activities","volume":"53","author":"Porta","year":"1989","journal-title":"Thromb Res"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0140","first-page":"39","article-title":"The effect of heparin on the plasma fibrinolytic activity","volume":"25","author":"Poplawski","year":"1974","journal-title":"Acta Physiol Pol"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0145","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/hrt.81.2.134","article-title":"Monocyte expression of tissue factor and adhesion molecules: The link with accelerated coronary artery disease in patients with chronic renal failure","volume":"81","author":"Pop Al-Saady","year":"1999","journal-title":"Heart"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0150","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1093\/ndt\/12.11.2355","article-title":"Plasma hypercoagulability in hemodialysis patients: Impact of dialysis and anticoagulation","volume":"12","author":"Ambuhl","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0155","first-page":"135","article-title":"Anticoagulation with nafamostat mesilate, a synthetic protease inhibitor, in hemodialysis patients with a bleeding risk","volume":"23","author":"Matsuo","year":"1993","journal-title":"Haemostasis"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0160","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ajh.1077","article-title":"Excessive anticoagulation in patients with mild renal insufficiency receiving long-term therapeutic enoxaparin","volume":"67","author":"Busby","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0165","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1023\/A:1008904310194","article-title":"Pharmacokinetics and pharmacodynamics of low-molecular weight heparins and glycoprotein IIb\/IIIa receptor antagonists in renal failure","volume":"11","author":"Smith","year":"2001","journal-title":"J Thromb Thrombolysis"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0170","first-page":"174","article-title":"Neutralization of DHG, a new depolymerized holothurian glycosaminoglycan, by protamine sulfate and platelet factor 4","volume":"27","author":"Sasaki","year":"1997","journal-title":"Haemostasis"},{"key":"10.1046\/j.1523-1755.2003.00879.x_bb0175","first-page":"47","article-title":"Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid: A prospective study","volume":"27","author":"Grassegger","year":"2001","journal-title":"Dermatol Surg"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815490349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815490349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T17:09:59Z","timestamp":1625245799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815490349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["S0085253815490349"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00879.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2003,4]]}}}